Reports on the arrest of herpes simplex virus type 1 (HSV-1) replication by interferon (IFN) are inconsistent. By the use of immunofluorescence and immunoblot assays with monoclonal and polyclonal antibodies, effective arrest of viral translation by human IFN-~ in human fibroblasts was detected for the HSV-1 strains KOS and Mclntyre. In HeLa cells which are less sensitive to IFN inhibition and in 444 cells, a HeLafibroblast hybrid cell line, the inhibition was less pronounced. These results confirm earlier observations that IFN or polyinosinic, polycytidylic acid block the replication of HSV-I in human, monkey and mouse cells no later than the immediate early phase of infection.
strain of HSV-1 were used. Human leukocyte IFN-~ and human fibroblast IFN-/~ inhibited all classes of HSV-1 proteins in that cell-virus combination. No impairment of HSV-1 transcription was found. Recently, Domke-Opitz et al. (1986) reconfirmed the IFN sensitivity of HSV-1 translation by using macrophages and natural and recombinant human IFN-c~ and -/L The above investigations demonstrate the sensitivity of HSV-1 translation towards natural or recombinant IFN-~ and -/~ of human, monkey or mouse origin. Mufioz & Carrasco (1984) published results not compatible with any of the foregoing. Their investigations were performed with the KOS strain of HSV-1, HeLa cells and human IFN-~ from leukocytes. Though infectious virus progeny was reduced after pretreatment of cells with 1000 units of IFN-~ per ml, there was little effect on the synthesis of any class of viral proteins, and even formation of virus particles was IFN-resistant. It was concluded that IFN leaves herpesvirus transcription, translation, genome replication and even morphogenesis intact and affects only the infectivity of the newly formed virus particles.
Chatterjee et al. (1985) presented a further reinvestigation using human fibroblasts, recombinant IFN-~ and -/~ and the HSV-1 strains F and MP. As in the foregoing study no significant inhibition of virus-specific protein synthesis was found, but the formation of two virus capsid glycoproteins was reduced and virion morphogenesis and release were arrested.
The conclusions from the latter two investigations are clearly inconsistent with the main conclusions drawn from all of the other references above. Considering the possibility that the use of different strains of HSV-1 might be responsible for the apparently different IFN inhibition mechanisms, we began a renewed study. The strain KOS (Mufioz & Carrasco, 1984) caused the greatest differences from the results of our investigations which were carried out exclusively using the Mclntyre strain (Lipp & Brandner, 1985) . We therefore directly compared the Mclntyre strain with KOS. In addition to low passage human fibroblasts (line ~1), HeLa calls (Mufioz & Carrasco, 1984) and 444 cells, a non-oncogenic hybrid between HeLa and human fibroblasts, were used as hosts. Virus was propagated on Vero cells and titrated on ~1 cells. All cell cultures were either free of mycoplasma contamination, ascertained by DNA fluorescence staining with Hoechst dye 33258, or were, in cases of slight contamination, decontaminated by treatment with 80 ~tg of ofloxacin per ml for one or two passages.
Human recombinant IFN-c~2C (Hu. rlFN-~2C, from E. Boehringer, Vienna, Austria) was added in Eagle's MEM (EMEM) with 3 to 5~ foetal calf serum (FCS) 18 h prior to infection. Dual positive cell controls were performed in the absence and the presence of either cytosine arabinoside (40 ~tg/ml) or phosphonoacetate (100 ~tg/ml) during infection to prevent any HSV-1 DNA replication. Virus-specific protein synthesis was estimated by immunofluorescence staining (Fig. 1) and counting the HSV-l-positive cells 7 h after infection. The antibodies used were either human polyclonal or mouse monoclonal. The human antibodies were selected from patients with high anti-HSV-1 ~ and/~ protein serum titres (Lipp & Brandner, 1980 . The monoclonal mouse antibodies were specific for the HSV-1 ~ protein ICP4 (Showalter et al., 1981) . This analysis was paralleled by an immunoblot analysis of extracts from treated infected cells and controls. The immunofluorescence assays with the selected human polyclonal sera and the monoclonal mouse anti-ICP4 antibody revealed similar numbers of infected cells in .all experiments.
In ~l cells both HSV-1 KOS and HSV-1 Mclntyre protein synthesis turned out to be highly sensitive to inhibition by IFN (Fig. 2) and the IFN dose dependence was the same as published previously for the Mclntyre strain (Lipp, 1981 ; Lipp & Brandner, 1985) . Inhibitors of HSV-1 DNA synthesis had no influence on the number of positive cells or the inhibition by IFN (data not shown). This demonstrated that in untreated infected cell cultures no secondary cycles of viral DNA replication had occurred 7 h after infection. On the other hand, both HSV-1 KOSand Mclntyre-specific translation was less IFN-sensitive in HeLa than in c~l cells, but not totally resistant as observed by Mufioz and Carrasco (1984) . The hybrid cell line 444 had an impaired IFN sensitivity similar to the parental HeLa cell line. Obviously fusion of HeLa cells with IFNsensitive fibroblasts was insufficient to confer full IFN sensitivity.
Immunoblot analysis of cell extracts from IFN-treated infected cells exhibited inhibition of HSV-1 translation in complete agreement with the quantitative immunofluorescence data (Fig. 3) .
In summary, these observations allow us to conclude (i) that virus-specific protein synthesis is IFN-sensitive both in HSV-1 KOS-and McIntyre-infected cells, (ii) that this inhibition is more pronounced in human diploid cells than in transformed human cells and (iii) that this effect seems to be independent of the IFN class (at or fl), species (human, monkey, murine) or source (natural or recombinant). The low IFN sensitivity of HeLa cells is well known (Lipp, 1981; Sakuragi & Simon, 1986) .
This reinvestigation provides no clues to explain the variant findings of Mufioz & Carrasco (1984) and of Chatterjee et al. (1985) . The question whether a particular step in HSV-1 genome expression, even before translation, could be arrested by IFN was not the goal of this reinvestigation, although from our previous studies with human fibroblasts the formation of normal viral transcripts is impaired (Lipp, 1981; Lipp & Brandner, 1985) . Even this more detailed insight leaves the mechanism of the virus specificity of this process obscure. The synergistic action of tumour necrosis factor ct plus IFN-~ causes an even more drastic inhibition 
